Pulsenmore Ltd. completed the CE European registration for Pulsenmore FC, a home ultrasound system designed for follicular monitoring during IVF and fertility preservation treatments. This regulatory approval under the European Medical Device Regulation enables the company to market and sell the device across European markets, marking its second product authorized in Europe and its first expansion beyond prenatal care into the broader women's health sector. The filing highlights a prior commercial agreement with Clalit Health Services in Israel and clinical study results demonstrating high agreement between home and in-clinic scans. Pulsenmore Ltd. is a healthcare technology company developing self-use ultrasound solutions for remote patient monitoring.
